These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13606730)

  • 1. The dermal barrier in systemic sclerosis and other rheumatic diseases.
    SHARP J; GOLDSBOROUGH D
    Ann Rheum Dis; 1958 Dec; 17(4):416-25. PubMed ID: 13606730
    [No Abstract]   [Full Text] [Related]  

  • 2. [Spreading factors, hyaluronidase and mucopolysaccharides; collagenase and collagen disease].
    JAUSION H; COUCHNER G
    Rev Pathol Comp; 1951 Jul; 51(630):64-98. PubMed ID: 14892636
    [No Abstract]   [Full Text] [Related]  

  • 3. [OBSERVATIONS ON THE NATURE OF COLLAGEN AND SIMILAR DISEASES WITH SPECIAL REFERENCE TO SYSTEMIC LUPUS ERYTHEMATOSUS. PATHOLOGIC SIGNIFICANCE OF AUTOIMMUNITY].
    FUJIMAKI S; OONISHI Y; URANO T
    Nisshin Igaku Jpn J Med Prog; 1963 Jul; 50():340-51. PubMed ID: 14087744
    [No Abstract]   [Full Text] [Related]  

  • 4. Reconstitution of dermal connective tissue barrier after testicular or bacterial hyaluronidase.
    JUHLIN L
    Acta Pharmacol Toxicol (Copenh); 1956; 12(1):96-108. PubMed ID: 13326468
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of antioxygens in therapy of collagen diseases].
    BERGEL M
    Sem Med; 1952 Jun; 100(25):807-11. PubMed ID: 14958453
    [No Abstract]   [Full Text] [Related]  

  • 6. RHEUMATIC MANIFESTATIONS OF COLLAGEN DISEASES.
    PERONI R
    Arch Interam Rheumatol; 1964 Sep; 7():377-87. PubMed ID: 14215799
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of ACTH and cortisone on dermal spread; suppressed action of hyaluronidase due to connective-tissue changes.
    ASBOE-HANSEN G
    Acta Endocrinol (Copenh); 1952 Jan; 9(1):29-36. PubMed ID: 14932691
    [No Abstract]   [Full Text] [Related]  

  • 8. Hyaluronidase activity in the skin, rheumatic disease, and salicylates.
    JONES ES
    Ann Rheum Dis; 1950 Jun; 9(2):137-48. PubMed ID: 15419618
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibodies reacting with cardiac tissue in patients with rheumatic diseases].
    Motovilov AA
    Ter Arkh; 1982; 54(10):83-6. PubMed ID: 6983732
    [No Abstract]   [Full Text] [Related]  

  • 10. [Collagen diseases within the framework of autoimmune diseases].
    Fanconi G
    Munch Med Wochenschr; 1966 Mar; 108(12):633-40. PubMed ID: 4383334
    [No Abstract]   [Full Text] [Related]  

  • 11. [THE LIVER IN THE RHEUMATIC-HYPERERGIC TYPE OF DISEASE].
    FALCK I
    Acta Hepatosplenol; 1963; 10():239-47. PubMed ID: 14051118
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE ELECTROLYTE COMPOSITION OF THE BLOOD SERUM AND ADRENOCORTICAL FUNCTION IN PATIENTS WITH COLLAGEN DISEASES].
    ZVERV ME
    Ter Arkh; 1963 Oct; 35():121-5. PubMed ID: 14145150
    [No Abstract]   [Full Text] [Related]  

  • 13. [Microcirculation in rheumatic diseases: instrumental findings].
    Vinci M; Giglio A; Paolinelli E; Raciti T
    Clin Ter; 1984 Jan; 108(1):59-65. PubMed ID: 6232043
    [No Abstract]   [Full Text] [Related]  

  • 14. [Roentgenokymography in the diagnosis of myocardial lesions in rheumatism and other collagenoses].
    Gusev NM
    Vopr Revm; 1977; (2):22-5. PubMed ID: 302525
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of hyaluronidase in the treatment of chronic skin ulcers in diffuse generalized scleroderma.
    POPKIN RJ
    Angiology; 1952 Aug; 3(4):335-42. PubMed ID: 14952881
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunopathology of collagen diseases].
    Strukov AI; Kop'eva TN; Kakturskiĭ LV
    Klin Med (Mosk); 1974 Jan; 52(1):20-30. PubMed ID: 4157037
    [No Abstract]   [Full Text] [Related]  

  • 17. The suppressive effects of benzpyrene on the manifestations of the increased tonus of the sympathetic nervous system: the influencing of the penetration of hyaluronidase in the skin of the rabbit.
    VRUBEL J
    Neoplasma; 1961; 8():22-6. PubMed ID: 13782251
    [No Abstract]   [Full Text] [Related]  

  • 18. [Microvessel ultrastructure in several diseases of rheumatologic interest].
    Cinti S; Sbarbati A; Grassi W
    Clin Ter; 1984 Jan; 108(1):24-41. PubMed ID: 6232039
    [No Abstract]   [Full Text] [Related]  

  • 19. [Histomorphological studies on the role of the bone marrow in rheumatic diseases].
    Burkhardt R
    Z Gesamte Exp Med Einschl Exp Chir; 1967; 143(1):1-66. PubMed ID: 4385191
    [No Abstract]   [Full Text] [Related]  

  • 20. Aberrant serum hyaluronan and hyaluronidase levels in scleroderma.
    Neudecker BA; Stern R; Connolly MK
    Br J Dermatol; 2004 Mar; 150(3):469-76. PubMed ID: 15030329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.